These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 38983924)

  • 1. Histone modifications in head and neck squamous cell carcinoma.
    Mao W; Wang B; Huang R; Sun Z; Yan M; Dong P
    Front Oncol; 2024; 14():1427725. PubMed ID: 38983924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing the role of epigenetic histone modification in targeting head and neck squamous cell carcinoma.
    Suchanti S; Stephen BJ; Awasthi S; Awasthi SK; Singh G; Singh A; Mishra R
    Epigenomics; 2022 Mar; 14(5):279-293. PubMed ID: 35184601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting histone deacetylases in head and neck squamous cell carcinoma: molecular mechanisms and therapeutic targets.
    Xu M; Hou Y; Li N; Yu W; Chen L
    J Transl Med; 2024 May; 22(1):418. PubMed ID: 38702756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Epigenetic Regulation on Head and Neck Squamous Cell Carcinoma.
    Bais MV
    J Dent Res; 2019 Mar; 98(3):268-276. PubMed ID: 30615537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC).
    Almeida LO; Abrahao AC; Rosselli-Murai LK; Giudice FS; Zagni C; Leopoldino AM; Squarize CH; Castilho RM
    FEBS Open Bio; 2014; 4():96-104. PubMed ID: 24490130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
    Sahafnejad Z; Ramazi S; Allahverdi A
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Modification in NSCLC: Molecular Mechanisms and Therapeutic Targets.
    Bajbouj K; Al-Ali A; Ramakrishnan RK; Saber-Ayad M; Hamid Q
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis.
    He L; Gao L; Shay C; Lang L; Lv F; Teng Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):84. PubMed ID: 30777099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone modifications: Targeting head and neck cancer stem cells.
    Le JM; Squarize CH; Castilho RM
    World J Stem Cells; 2014 Nov; 6(5):511-25. PubMed ID: 25426249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles and regulation of histone acetylation in hepatocellular carcinoma.
    Xia JK; Qin XQ; Zhang L; Liu SJ; Shi XL; Ren HZ
    Front Genet; 2022; 13():982222. PubMed ID: 36092874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101.
    Duan J; Friedman J; Nottingham L; Chen Z; Ara G; Van Waes C
    Mol Cancer Ther; 2007 Jan; 6(1):37-50. PubMed ID: 17237265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Modifications in Head and Neck Cancer.
    Gaździcka J; Gołąbek K; Strzelczyk JK; Ostrowska Z
    Biochem Genet; 2020 Apr; 58(2):213-244. PubMed ID: 31712935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma.
    Murali M; Saloura V
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36360250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head and Neck Squamous Cell Carcinoma: Epigenetic Landscape.
    Romanowska K; Sobecka A; Rawłuszko-Wieczorek AA; Suchorska WM; Golusiński W
    Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33375464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
    Castilho RM; Squarize CH; Almeida LO
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D and the epigenome.
    Fetahu IS; Höbaus J; Kállay E
    Front Physiol; 2014; 5():164. PubMed ID: 24808866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Vitamin D in Head and Neck Cancer-Immune Function, Anti-Tumour Effect, and Its Impact on Patient Prognosis.
    Starska-Kowarska K
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The promise and failures of epigenetic therapies for cancer treatment.
    Bojang P; Ramos KS
    Cancer Treat Rev; 2014 Feb; 40(1):153-69. PubMed ID: 23831234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone H3K9 modifications are a local chromatin event involved in ethanol-induced neuroadaptation of the NR2B gene.
    Qiang M; Denny A; Lieu M; Carreon S; Li J
    Epigenetics; 2011 Sep; 6(9):1095-104. PubMed ID: 21814037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of Histone Acetyltransferases and Deacetylases in the Retinal Development and Diseases.
    Wang J; Feng S; Zhang Q; Qin H; Xu C; Fu X; Yan L; Zhao Y; Yao K
    Mol Neurobiol; 2023 Apr; 60(4):2330-2354. PubMed ID: 36637745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.